Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Osteoporosis

Original research

Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses

Online download statistics by month:

Online download statistics by month: September 2020 to December 2022

	Abstract	Full	Pdf
Sep 2020	474	482	100
Oct 2020	174	173	33
Nov 2020	75	74	28
Dec 2020	48	45	20
Jan 2021	88	82	59
Feb 2021	119	118	32
Mar 2021	52	51	16
Apr 2021	38	36	12
May 2021	27	27	19
Jun 2021	30	28	15
Jul 2021	52	50	31
Aug 2021	43	43	17
Sep 2021	26	24	15
Oct 2021	47	47	40
Nov 2021	26	25	24
Dec 2021	36	34	10
Jan 2022	26	25	10
Feb 2022	35	39	17
Mar 2022	55	58	22
Apr 2022	48	53	22
May 2022	51	51	14
Jun 2022	48	47	20
Jul 2022	27	27	6
Aug 2022	40	40	13
Sep 2022	30	31	19
Oct 2022	48	48	11
Nov 2022	38	36	17
Dec 2022	25	24	12
Total	1826	1818	654